Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeDung T. Le, Luis A. Díaz, Fay Wong et al.|Science|2017Cited by 6.6k
Soft Tissue Sarcoma, Version 2.2014Margaret von Mehren, Hema Sundar, R. Lor Randall et al.|Journal of the National Comprehensive Cancer Network|2014Cited by 150
Soft Tissue Sarcoma, Version 2.2012Margaret von Mehren, Nicole R. McMillian, Robert S. Benjamin et al.|Journal of the National Comprehensive Cancer Network|2012Cited by 149
Gastrointestinal Stromal Tumors, Version 2.2014Margaret von Mehren, Hema Sundar, R. Lor Randall et al.|Journal of the National Comprehensive Cancer Network|2014Cited by 132
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)Brigitte C. Widemann, John P. Perentesis, Yao Lu et al.|Sarcoma|2019Cited by 74